Pa. Pizzo et C. Wilfert, ANTIRETROVIRAL THERAPY FOR INFECTION DUE TO HUMAN-IMMUNODEFICIENCY-VIRUS IN CHILDREN, Clinical infectious diseases, 19(1), 1994, pp. 177-196
Infection with human immunodeficiency virus type 1 (HIV-1) in children
presents problems that greatly differ from those seen in adults. The
great majority of children are infected either during gestation or at
the time of birth. As Drs. Pizzo and Wilfert note in their AIDS Commen
tary, this results in rapid development of immunosuppression and clini
cal manifestations in patients whose immune systems are in the process
of maturing. Thus, a thorough understanding of the pharmacokinetics o
f antiretroviral agents in infants and small children is required. Thi
s AIDS Commentary provides a comprehensive review of the current state
of our knowledge and possible future directions for the management of
HIV-1 infection in this young population.